Kisspeptin is present in ovine hypophysial portal blood but does not increase during the preovulatory luteinizing hormone surge: evidence that gonadotropes are not direct targets of kisspeptin in vivo.
Smith. J T JT; Rao. A A; Pereira. A A; Caraty. A A; Millar. R P RP; Clarke. I J IJ
Key Findings
- Kisspeptin receptors are present in sheep pituitary cells that produce LH, GH, and prolactin.
- In vitro, kisspeptin raised LH release by about 80% but only in pituitary cultures from ewes in the follicular phase.
- In vivo, kisspeptin did not alter LH levels, and portal blood kisspeptin concentrations were low and unchanged during an estrogen‑induced LH surge.
Practical Outcomes
- For DIY hormone enthusiasts, taking kisspeptin is unlikely to directly increase LH or testosterone via the pituitary. Any hormonal effects would have to come from central (brain) action, so kisspeptin isn’t a straightforward tool for boosting reproductive hormones in self‑experiments.
Summary
The study shows that while kisspeptin can boost LH hormone release in lab-grown sheep pituitary cells under specific conditions, it doesn’t have the same effect in live animals, and the amount of kisspeptin in blood flowing to the pituitary is very low and unchanged during hormone surges. This means kisspeptin mainly works by acting on the brain, not directly on the pituitary gland.
Abstract
There is strong evidence that kisspeptin acts to regulate GnRH secretion, but whether there is also a component of action on the gonadotropes is not clear. Using quantitative RT-PCR, we found that G protein-coupled receptor-54 mRNA is expressed in ovine pituitary cell fractions enriched for gonadotropes as well as in somatotropes and lactotropes. To test whether kisspeptin acts directly on the pituitary gonadotropes, we first examined LH release from primary ovine pituitary cell cultures treated with kisspeptin. We found that kisspeptin treatment increased the concentration of LH in culture media by 80%, compared with control, but only in pituitary cultures from ewes during the follicular phase of the estrous cycle. After this, we determined whether kisspeptin acts on the pituitary gland in vivo. Using GnRH-replaced ovariectomized hypothalamo-pituitary-disconnected ewes, we were not able to achieve any effect of kisspeptin on LH under steady-state conditions or during the period of an estrogen-induced LH surge. Finally, we collected hypophysial portal blood samples from ovariectomized ewes and measured kisspeptin levels. Low but detectable amounts of kisspeptin were found in portal plasma, but levels were similar in ovariectomized ewes that were untreated or given estrogen to elicit an LH surge. Thus, although we observed an effect of kisspeptin on LH release in vitro in some situations, similar findings were not obtained in vivo. Moreover, the low concentrations of kisspeptin in hypophysial portal blood and the lack of any change during the period of an estrogen-induced GnRH/LH surge suggest that action on the pituitary gland is not of major consequence in terms of LH release.
Study Information
pubmed
2007
2007-12-27T00:00:00.000Z
10.1210/en.2007-1425